Wataru Satake

Tokyo, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 60 publications

Comparator supplement patterns qualify the clinical interpretation of an EHR-derived glucosamine signal in Alzheimer's disease.

Comparator supplement patterns qualify the clinical interpretation of an EHR-derived glucosamine signal in Alzheimer's disease.

Journal: medRxiv : the preprint server for health sciences

Published: August 20, 2026

Response to: Autosomal Dominant TWNK Mutations more likely Manifest with Multisystem Disease than Isolated External Ophthalmoplegia.

Response to: Autosomal Dominant TWNK Mutations more likely Manifest with Multisystem Disease than Isolated External Ophthalmoplegia.

Journal: Internal medicine (Tokyo, Japan)

Published: August 19, 2026

Subthreshold early white-matter hyperintensity increase predicts accelerated hippocampal and whole-brain atrophy in anti-amyloid-β immunotherapy.

Subthreshold early white-matter hyperintensity increase predicts accelerated hippocampal and whole-brain atrophy in anti-amyloid-β immunotherapy.

Journal: Journal of Alzheimer's disease : JAD

Published: August 08, 2026

A de novo TWNK Variant Mimicked Sporadic Chronic Progressive External Ophthalmoplegia.

A de novo TWNK Variant Mimicked Sporadic Chronic Progressive External Ophthalmoplegia.

Journal: Internal medicine (Tokyo, Japan)

Published: June 28, 2026

Delayed appearance of bilateral cerebral peduncle lesions in autoimmune glial fibrillary acidic protein astrocytopathy: A serial MRI case series.

Delayed appearance of bilateral cerebral peduncle lesions in autoimmune glial fibrillary acidic protein astrocytopathy: A serial MRI case series.

Journal: Journal of the neurological sciences

Published: June 04, 2026

Mapping U.S. POINTER Cognitive-Slope Gains Onto Predicted Clinical Progression: An External-Cohort Translation Analysis With Exploratory Economic Thresholds.

Mapping U.S. POINTER Cognitive-Slope Gains Onto Predicted Clinical Progression: An External-Cohort Translation Analysis With Exploratory Economic Thresholds.

Journal: medRxiv : the preprint server for health sciences

Published: June 04, 2026

Persistent parkinsonism with dopaminergic denervation following axicabtagene ciloleucel therapy for diffuse large B cell lymphoma: a case report.

Persistent parkinsonism with dopaminergic denervation following axicabtagene ciloleucel therapy for diffuse large B cell lymphoma: a case report.

Journal: International journal of hematology

Published: April 30, 2026

Early adoption of lecanemab in Japan (December 2023-December 2024): Pretreatment diagnostic timelines from the DeSC claims database.

Early adoption of lecanemab in Japan (December 2023-December 2024): Pretreatment diagnostic timelines from the DeSC claims database.

Journal: Journal of Alzheimer's disease : JAD

Published: April 21, 2026

Successful Bortezomib-Lenalidomide-Dexamethasone Therapy in a 72-Year-Old Patient With Sporadic Late-Onset Nemaline Myopathy Associated With Monoclonal Gammopathy of Muscle Significance.

Successful Bortezomib-Lenalidomide-Dexamethasone Therapy in a 72-Year-Old Patient With Sporadic Late-Onset Nemaline Myopathy Associated With Monoclonal Gammopathy of Muscle Significance.

Journal: Muscle & nerve

Published: March 27, 2026

Therapeutic Time Window of Disease-Modifying Therapy for Early Alzheimer's Disease in Japanese Individuals: Analysis Based on J-ADNI Study.

Therapeutic Time Window of Disease-Modifying Therapy for Early Alzheimer's Disease in Japanese Individuals: Analysis Based on J-ADNI Study.

Journal: Geriatrics & gerontology international

Published: November 18, 2025

Genotype-phenotype correlations in neuronal intranuclear inclusion disease-related retinopathy with CGG repeat increases in NOTCH2NLC.

Genotype-phenotype correlations in neuronal intranuclear inclusion disease-related retinopathy with CGG repeat increases in NOTCH2NLC.

Journal: Journal of neurology

Published: November 03, 2025

Subacute Progression of Gait Disturbance and Consciousness Impairment Due to Communicating Hydrocephalus Associated With Vestibular Schwannoma.

Subacute Progression of Gait Disturbance and Consciousness Impairment Due to Communicating Hydrocephalus Associated With Vestibular Schwannoma.

Journal: Cureus

Published: August 12, 2025

Showing 1-12 of 60

Last Updated: 09/26/2026